12:00 AM
 | 
Jan 04, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Combidex magnetic resonance imaging contrast agent regulatory update

AVM submitted an NDA to the FDA for Combidex to diagnose lymph node diseases to...

Read the full 55 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >